title: Case report of exposure to voriconazole in the second and third trimesters of pregnancy.
authors.forename: M
authors.initials: M
authors.lastname: Shoai Tehrani
authors.forename: F
authors.initials: F
authors.lastname: Sicre de Fontbrune
authors.forename: P
authors.initials: P
authors.lastname: Roth
authors.forename: C
authors.initials: C
authors.lastname: Allisy
authors.forename: M-E
authors.initials: ME
authors.lastname: Bougnoux
authors.forename: O
authors.initials: O
authors.lastname: Hermine
authors.forename: M
authors.initials: M
authors.lastname: Lecuit
authors.forename: O
authors.initials: O
authors.lastname: Lortholary
authors.forename: C
authors.initials: C
authors.lastname: Charlier
mesh_terms: D000328:Adult; D001228:Aspergillosis / Q000188:drug therapy*; D001231:Aspergillus flavus / Q000187:drug effects / Q000302:isolation & purification; D005260:Female; D006801:Humans; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D011743:Pyrimidines / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D014230:Triazoles / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D065819:Voriconazole
chemical_list: D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole